Relative bioavailability in humans for oral tablets and solutions of lormetazepam. 1985

L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini

A study was carried out to estimate the relative bioavailability of 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-1, 3-dihydro-1H-1,4-benzodiazepine-2-one (lormetazepam, Minias) in humans after administration of oral tablets and solutions. Plasma concentration of the drug was measured by gaschromatography with electron capture detector. Six healthy males were each given both formulations. With the oral solution higher plasma peak concentration and a shorter peak time were observed than with tablets. Also the elimination half-life was shorter with the oral solution, while no difference was found with the AUC.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008297 Male Males
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds

Related Publications

L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
September 1978, Journal of pharmaceutical sciences,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
December 1978, Journal of pharmaceutical sciences,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
January 1998, European journal of drug metabolism and pharmacokinetics,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
January 1987, Current medical research and opinion,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
January 1982, Biopharmaceutics & drug disposition,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
January 1988, Gaceta medica de Mexico,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
April 1995, Methods and findings in experimental and clinical pharmacology,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
September 1979, Journal of pharmaceutical sciences,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
September 1985, Journal of pharmaceutical sciences,
L Zecca, and L Reina, and F Scaglione, and P Ferrario, and R Pirola, and G Ceccarelli, and M Ciampini, and F Fraschini
May 1995, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!